From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults

J Geriatr Oncol. 2019 May;10(3):384-388. doi: 10.1016/j.jgo.2019.01.023. Epub 2019 Feb 8.

Authors

Kah Poh Loh¹, Melisa L Wong², Ronald Maggiore³

Affiliations

¹ Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: kahpoh_loh@urmc.rochester.edu.
² Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
³ Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.

PMID: 30745116
DOI: 10.1016/j.jgo.2019.01.023

No abstract available

Keywords: Clinical trials; Immune checkpoint inhibitors; Older adults; Real-world.

Publication types

Editorial
Review

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents, Immunological / therapeutic use*
Clinical Trials as Topic
Humans
Middle Aged
Neoplasms / drug therapy*
Retrospective Studies

Substances

Antineoplastic Agents, Immunological